US Congress House Bill 2005 (Prior Session Legislation)

---

Spectrum: Partisan Bill (Democrat 16-0)
Status: Introduced on April 23 2015 - 25% progression, died in committee
Action: 2015-05-13 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]

Medicare Drug Savings Act of 2015 Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act (SSAct) to require drug manufacturers to pay the Secretary of Health and Human Services drug rebates for rebate eligible (low-income) individuals. Excludes from Medicare coverage as a part D drug any drug or biological manufactured by a manufacturer that has not entered into and have in effect a rebate agreement with the Secretary. Requires a rebate agreement to require a drug or biological manufacturer to provide to the Secretary a rebate, determined according to a specified formula, for each rebate period ending after December 31, 2015, for any covered Medicare part D drug dispensed after that date to any rebate eligible individual for which payment was made by a prescription drug plan sponsor or MedicareAdvantage organization for such period. Specifies a formula for determination of Medicaid rebate amounts for such drugs or biologicals. Amends SSAct title XIX (Medicaid) to exclude any amounts paid under a rebate agreement from the determination of best price and average manufacturer price under the Medicaid program.

Medicare Drug Savings Act of 2015

Rep. Kathy Castor [D-FL]	Rep. Sander Levin [D-MI]	Rep. Matthew Cartwright [D-PA]	Rep. Corrine Brown [D-FL]
Rep. Mark Pocan [D-WI]	Rep. Barbara Lee [D-CA]	Rep. Raul Grijalva [D-AZ]	Rep. Janice Schakowsky [D-IL]
Rep. Alan Lowenthal [D-CA]	Rep. Mark Takano [D-CA]	Rep. Dina Titus [D-NV]	Rep. Mark DeSaulnier [D-CA]
Rep. Donna Edwards [D-MD]	Rep. Michael Honda [D-CA]	Rep. Don Beyer [D-VA]	Rep. Earl Blumenauer [D-OR]

Date	Chamber	Action
2015-05-13	House	Referred to the Subcommittee on Health.
2015-04-24	House	Referred to the Subcommittee on Health.
2015-04-23	House	Referred to House Ways and Means
2015-04-23	House	Referred to House Energy and Commerce
2015-04-23	House	Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2015-04-23	House	Introduced in House

SB1083 (Same As) 2015-04-23 - Read twice and referred to the Committee on Finance.
HB3513 (Related) 2015-09-18 - Referred to the Subcommittee on Health.
SB2023 (Related) 2015-09-10 - Read twice and referred to the Committee on Finance.

Type	Source
Summary	https://www.congress.gov/bill/114th-congress/house-bill/2005/all-info
Text	https://www.congress.gov/114/bills/hr2005/BILLS-114hr2005ih.pdf